Drugs / Intradermal influenza vaccine
Trials 1 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 3 | NCT02103023 | Mar → Nov 2014 | influenza | The University of Hong Kong | Completed | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Intradermal influenza vaccine | ClinicalTrials.gov intervention name — accepted as the source's own label NCT02103023 ↗ |
| Known as | Intanza15 | “intradermal trivalent influenza vaccine (Intanza15)” NCT02103023 ↗ |
| Modality | Vaccine | “intradermal trivalent influenza vaccine (Intanza15)” NCT02103023 ↗ |